Stefan Bröer is looking for the right molecule for a biological target, that could be developed into a drug to treat diabetes. Now ANU has its own library of compounds, available to biological and medical researchers, managed by the Research School of Chemistry.
They say leaders are born not made, but it seems the opposite is true for queen bees, according to a new study by researchers from The Australian National University (ANU) and Queen Mary University of London.
New research from The Australian National University (ANU) has drilled down to the molecular level to find similarities across six pharmaceutical drugs used in pain relief, dentist anaesthetic, and treatment of epilepsy, in a bid to find a way to reduce unwanted side-effects.
F1Fo ATP synthase generates the majority of cellular energy by interconverting phosphate transfer energy and proton motive force via a rotary catalytic mechanism. Using cryo electron microscopy we have provided molecular snapshots of this complex enzyme in multiple states.
The Acinetobacter genus includes at least 70 named species that occupy environments which differ broadly in nutrient composition, water availability, temperature and other abiotic characteristics.
Malaria remains the deadliest parasitic disease in the world despite years of sustained effort, new drug development, and a greater understanding of the causative parasite, Plasmodium, and its interactions with its host.
Developing novel synthetic microbes for the sustainable production of biochemical, biofuels and bioplastics is critical for the emergence of a new global bioeconomy.
One of the most fundamental assumptions in biology is that the amino acid sequence defines protein structure and that this sequence carries no memory of the specific mRNA codon sequence from which it was translated.